# Biomat USA, Inc. – FDA Inspection, Oct 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/50f2f7ed-a3fb-498e-a0af-1f0360d52951
Source feed: FDA_Inspections

> FDA inspection 1071044 of Biomat USA, Inc., October 18, 2018. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1071044
- Company Name: Biomat USA, Inc.
- Inspection Date: 2018-10-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 988681 - 2016-10-06
- FDA Inspection 865425 - 2014-02-05
- [FDA Inspection 785185 - 2012-04-24](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7ed59914-3936-4e1e-8527-8102e82d79a6)
- FDA Inspection 669894 - 2010-06-23

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kathryn-a-krentz/9523b161-3b81-4a1b-aaca-c0406d756ab4)
- Issuing Officer

Company: https://www.keypedia.com/companies/biomat-usa-inc/3d78beed-9bd4-4c2a-8a22-7ace9fbd1a46

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d